Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Open accessThe DOI matches its Crossref record; 662 of the 664 references it cites were found in a registry or an index.
Abstract
Objective: To provide an update to “Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012.” Design: A consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for those committee members attending the conference). A formal conflict-of-interest (COI) policy was developed at the onset of the process and enforced throughout. A stand-alone meeting was held for all panel members in December 2015. Teleconferences and electronic-based discussion among subgroups and among the entire committee served as an integral part of the development. Methods: The panel consisted of five sections: hemodynamics, infection, adjunctive therapies, metabolic, and ventilation. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. Each subgroup generated a list of questions, searched for best available evidence, and then followed the principles of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to assess the quality of evidence from high to very low, and to formulate recommendations as strong or weak, or best practice statement when applicable. Results: The Surviving Sepsis Guideline panel provided 93 statements on early management and resuscitation of patients with sepsis or septic shock. Overall, 32 were strong recommendations, 39 were weak recommendations, and 18 were best-practice statements. No recommendation was provided for four questions. Conclusions: Substantial agreement exists among a large cohort of international experts regarding many strong recommendations for the best care of patients with sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the SSC 2016 guidelines, we issued a weak recommendation for using NMBA infusion for 48 h in sepsis-induced moderate to severe ARDS [12, 13].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous versions of SSC guidelines issued a strong recommendation with a moderate-quality evidence for using low tidal volume (Vt) ventilation (Vt 4–8 mL/kg of predicted body weight), over higher tidal volumes (Vt > 8 mL/kg) in the management of patients with ARDS [12, 13, 226].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Considering the increasing frequency of MDR bacteria in many parts of the world and associations between delays in active therapy and worse outcomes, the initial use of multidrug therapy is often required to ensure the empiric regimen includes at least one effective agent that is active against the offending organism (12,13).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Appropriate source control is a key principle in the management of sepsis and septic shock (12,13).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“Considering the increasing frequency of MDR bacteria in many parts of the world and associations between delays in active therapy and worse outcomes, the initial use of multidrug therapy is often required to ensure the empiric regimen includes at least one effective agent that is active against the offending organism [12, 13].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [12]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Boldt, J., Heesen, M. A., Müller, M., Pabsdorf, M., & Hempelmann, G. (1996) · Anesthesia & Analgesia · doi:10.1097/00000539-199608000-00010 · Cited by 137
RetractedInfluence of different volume therapies on platelet function in the critically ill
Boldt, J., Müller, M., Heesen, M. A., Heyn, O., & Hempelmann, G. (1996) · Intensive Care Medicine · doi:10.1007/bf01699231 · Cited by 54
RetractedThe SAFE study: saline vs. albumin for fluid resuscitation in the critically ill
Finfer, S., Norton, R., Bellomo, R., Boyce, N., French, J., & Myburgh, J. (2004) · Vox Sanguinis · doi:10.1111/j.1741-6892.2004.00468.x · Cited by 48
Self-citationRetractedBoldt, J., Heesen, M. A., Welters, I. D., Padberg, W. M., Martin, K. M., & Hempelmann, G. (1995) · British Journal of Anaesthesia · doi:10.1093/bja/75.6.740 · Cited by 47
RetractedThe third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationGRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citation
Research works printed but not linked: 7
- Blot, 2014, Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study., Crit Care, 18, R99, 10.1186/cc13874 · DOI
- Yealy, 2014, A randomized trial of protocol-based care for early septic shock., N Engl J Med, 370, 1683, 10.1056/nejmoa1401602 · DOI · Paper page
- Peake, 2014, Goal-directed resuscitation for patients with early septic shock., N Engl J Med, 371, 1496, 10.1056/nejmoa1404380 · DOI · Paper page
- Meade, 2008, Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial., JAMA, 299, 637, 10.1001/jama.299.6.637 · DOI · Paper page
- Matthay, 2011, Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury., Am J Respir Crit Care Med, 184, 561, 10.1164/rccm.201012-2090oc · DOI · Paper page
- Ouellette, 2016, Liberation from mechanical ventilation: an official American College of Chest Physicians/American Thoracic Society clinical practice guideline: inspiratory pressure augmentation during spontaneous breathing trials, protocols minimizing sedation, and non-invasive ventilation immediately after extubation., Chest
- 2014, Standards of medical care in diabetes—2014., Diabetes Care, 37 Suppl 1, S14
Cited by
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Self-citationSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citationPadmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Cecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30696-2 · Cited by 2,254
Self-citation
Metadata
- Authors
- Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., Rochwerg, B., Rubenfeld, G. D., Angus, D. C., Annane, D., Beale, R. J., Bellinghan, G. J., Bernard, G. R., Chiche, J.-D., Coopersmith, C., De Backer, D. P., French, C. J., Fujishima, S., Gerlach, H., Hidalgo, J. L., Hollenberg, S. M., Jones, A. E., Karnad, D. R., Kleinpell, R. M., Koh, Y., Lisboa, T. C., Machado, F. R., Marini, J. J., Marshall, J. C., Mazuski, J. E., McIntyre, L. A., McLean, A. S., Mehta, S., Moreno, R. P., Myburgh, J., Navalesi, P., Nishida, O., Osborn, T. M., Perner, A., Plunkett, C. M., Ranieri, M., Schorr, C. A., Seckel, M. A., Seymour, C. W., Shieh, L., Shukri, K. A., Simpson, S. Q., Singer, M., Thompson, B. T., Townsend, S. R., Van der Poll, T., Vincent, J.-L., Wiersinga, W. J., Zimmerman, J. L., & Dellinger, R. P.
- Affiliations
- St George's Hospital (GB)
- New York University (US)
- McMaster University (CA)
- Brown University (US)
- Università Cattolica del Sacro Cuore (IT)
- Vall d'Hebron Hospital Universitari (ES)
- University of Manitoba (CA)
- Emory University Hospital (US)
- Hadassah Medical Center (IL)
- CHIREC Hospitals Braine L’Alleud, Belgium.
- Vivantes Klinikum (DE)
- University of Mississippi Medical Center (US)
- Rush University Medical Center (US)
- Asan Medical Center (KR)
- Hospital de Clínicas de Porto Alegre (BR)
- Federal University of Sao Paulo Sao Paulo, Brazil.
- Regions Hospital (US)
- St. Michael's Hospital (CA)
- Ottawa Hospital (CA)
- The University of Sydney (AU)
- Mount Sinai Hospital (CA)
- Unidade Local de Saúde de São José (PT)
- UNSW Sydney (AU)
- Magna Graecia University (IT)
- Fujita Health University (JP)
- Università Sapienza, Rome, Italy.
- University of Pittsburgh (US)
- Stanford Medicine (US)
- University of Kansas Medical Center (US)
- University of Amsterdam Amsterdam, Netherlands.
- Erasmus Hospital (BE)
- Houston Methodist (US)
- ORCID
- Rhodes, Andrew
- Evans, Laura E.
- Alhazzani, Waleed
- Levy, Mitchell M.
- Antonelli, Massimo
- Ferrer, Ricard
- Kumar, Anand
- Sprung, Charles L.
- Nunnally, Mark E.
- Rochwerg, Bram
- Angus, Derek C.
- Annane, Djillali
- Bernard, Gordon R.
- Chiche, Jean-Daniel
- Coopersmith, Craig
- French, Craig J.
- Fujishima, Seitaro
- Gerlach, Herwig
- Hidalgo, Jorge Luis
- Hollenberg, Steven M.
- Jones, Alan E.
- Karnad, Dilip R.
- Kleinpell, Ruth M.
- Koh, Younsuck
- Lisboa, Thiago Costa
- Marini, John J.
- Marshall, John C.
- McIntyre, Lauralyn A.
- McLean, Anthony S.
- Mehta, Sangeeta
- Moreno, Rui P.
- Myburgh, John
- Navalesi, Paolo
- Nishida, Osamu
- Osborn, Tiffany M.
- Perner, Anders
- Schorr, Christa A.
- Seckel, Maureen A.
- Seymour, Christopher W.
- Shieh, Lisa
- Simpson, Steven Q.
- Singer, Mervyn
- Thompson, B. Taylor
- Vincent, Jean-Louis
- Wiersinga, W. Joost
- Venue
- Critical Care Medicine
- Published
- 2017-03
- Volume
- 45
- Issue
- 3
- Pages
- 486-552
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W3045454797
- Cited by
- 3,652
- References
- 664
- Citations by year
- 2026: 74 · 2025: 115 · 2024: 200 · 2023: 257 · 2022: 376 · 2021: 653 · 2020: 686 · 2019: 557 · 2018: 471 · 2017: 248
- FWCI
- 420.35
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- American Thoracic Society
- Pfizer
- CSL Behring
- European Respiratory Society
- American Association of Critical-Care Nurses
- Strong
- Società Italiana Anestesia, Analgesia, Rianimazione e Terapia Intensiva
- Intensive Care Society
- Japanese Respiratory Society
- European Society of Anaesthesiology
- European Society of Intensive Care Medicine
- Grifols
- Centers for Disease Control and Prevention
- Allergan
- Abbott Diagnostics
- Japan Society for the Promotion of Science (26462767)
- National Institute of General Medical Sciences (R35GM119519)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- sepsis, septic shock, sepsis treatment, sepsis resuscitation, hemodynamic management, infection management, adjunctive therapy, metabolic control, mechanical ventilation, critically ill patients, sepsis mortality
- MeSH terms
- Anti-Bacterial Agents, Critical Care, Fluid Therapy, Humans, Intensive Care Units, Respiration, Artificial, Resuscitation, Shock, Septic, Nutritional Support, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. https://app.cochat.ai/papers/10.1097/ccm.0000000000002255
- The paper
- Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., Rochwerg, B., Rubenfeld, G. D., Angus, D. C., Annane, D., Beale, R. J., Bellinghan, G. J., Bernard, G. R., Chiche, J.-D., Coopersmith, C., . . . Dellinger, R. P. (2017). Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Critical Care Medicine. https://doi.org/10.1097/ccm.0000000000002255
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.